Abacavir + Lamivudine

Composition

The formulation contains Abacavir 120mg + Lamivudine 60mg Tablet: Contains abacavir 120mg and lamivudine 60mg as the active ingredients.

Indications

HIV infection in pediatric patients

Side effects

Hypersensitivity reactions, nausea, headache

Precautions

Screen for HLA-B*5701 allele due to risk of hypersensitivity

Contraindications

Positive HLA-B*5701 allele, moderate to severe liver impairment

Dosage and administration

Based on weight and clinical condition

Countries

UK, India, Australia

Available Forms

Tablets

Manufacturing Services

Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai